Abstract
Cytochrome P450 17α-hydroxylase (P450c17) enzyme, encoded by the CYP17A1 gene, catalyzes 17a-hydroxylation and 17,20-lyase reactions essential for cortisol and sex steroid synthesis. 17α-hydroxylase/17,20-lyase deficiency (17OHD) is a rare autosomal recessive disease caused by CYP17A1 mutations, classified into complete and partial forms based on P450c17 defect severity. We report two unrelated girls diagnosed with 17OHD at the age of 15 and 16. Both presented with primary amenorrhea, infantile genitalia, absent axillary and pubic hair, and hypergonadotropic hypogonadism. Case 1 exhibited undeveloped breasts, nocturnal enuresis, hypertension, hypokalemia, and reduced cortisol and 17α-hydroxyprogesterone. Case 2 showed a growth spurt, spontaneous breast development, elevated corticosterone, and decreased aldosterone. Both had a 46,XX karyotype. Genetic analysis revealed a homozygous p.S106P mutation in Case 1 and compound heterozygous p.R347C/p.R362H mutations in Case 2, with the latter representing a novel combination. Based on the clinical, laboratory and genetic findings, Case 1 and Case 2 were definitively diagnosed as complete and partial forms of 17OHD, respectively. Both received estrogen and glucocorticoid replacement therapy, leading to gradual development of the uterus and breasts, and the onset of first menstruation. In Case 1, hypertension, hypokalemia, and nocturnal enuresis were significantly alleviated. In conclusion, we report the first case of complete 17OHD accompanied by nocturnal enuresis and identify a novel compound heterozygote (p.R347C / p.R362H) of CYP17A1 gene in a case of partial 17OHD.
Keywords: Congenital adrenal hyperplasia, 17α-hydroxylase/17, 20-lyase deficiency, CYP17A1 gene, mutation, nocturnal enuresis
Read the full text
4 sections · 2 figures · 3 tables · PDF
Create your free account to read the full text.
- Full text with figures and tables
- PDF and supplementary files
- Access on every Galenos journal
One Galenos account works on every Galenos journal site.
References
El-Maouche D, Arlt W, Merke DP. Congenital adrenal hyperplasia. Lancet. 2017;390:2194-2210. Epub 2017 May 30 Erratum in: Lancet. 2017;390:2142.
Geller DH, Auchus RJ, Mendonça BB, Miller WL. The genetic and functional basis of isolated 17,20-lyase deficiency. Nat Genet. 1997;17:201-205.
Auchus RJ, Miller WL. Molecular modeling of human P450c17 (17alpha-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations. Mol Endocrinol. 1999;13:1169-1182.
Costa-Santos M, Kater CE, Auchus RJ; Brazilian Congenital Adrenal Hyperplasia Multicenter Study Group. Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency. J Clin Endocrinol Metab. 2004;89:49-60.
Podgórski R, Aebisher D, Stompor M, Podgórska D, Mazur A. Congenital adrenal hyperplasia: clinical symptoms and diagnostic methods. Acta Biochim Pol. 2018;65:25-33. Epub 2018 Mar 15
Tian Q, Zhang Y, Lu Z. Partial 17alpha-hydroxylase/17,20-lyase deficiency-clinical report of five Chinese 46,XX cases. Gynecol Endocrinol. 2008;24:362-367.
Lin D, Harikrishna JA, Moore CC, Jones KL, Miller WL. Missense mutation serine106----proline causes 17 alpha-hydroxylase deficiency. J Biol Chem. 1991;266:15992-15998.
Fardella CE, Zhang LH, Mahachoklertwattana P, Lin D, Miller WL. Deletion of amino acids Asp487-Ser488-Phe489 in human cytochrome P450c17 causes severe 17 alpha-hydroxylase deficiency. J Clin Endocrinol Metab. 1993;77:489-493.
Monno S, Ogawa H, Date T, Fujioka M, Miller WL, Kobayashi M. Mutation of histidine 373 to leucine in cytochrome P450c17 causes 17 alpha-hydroxylase deficiency. J Biol Chem. 1993;268:25811-25817.
Fardella CE, Hum DW, Homoki J, Miller WL. Point mutation of Arg440 to His in cytochrome P450c17 causes severe 17 alpha-hydroxylase deficiency. J Clin Endocrinol Metab. 1994;79:160-164.
Geller DH, Auchus RJ, Miller WL. P450c17 mutations R347H and R358Q selectively disrupt 17,20-lyase activity by disrupting interactions with P450 oxidoreductase and cytochrome b5. Mol Endocrinol. 1999;13:167-175.
Meng L, Pammi M, Saronwala A, Magoulas P, Ghazi AR, Vetrini F, Zhang J, He W, Dharmadhikari AV, Qu C, Ward P, Braxton A, Narayanan S, Ge X, Tokita MJ, Santiago-Sim T, Dai H, Chiang T, Smith H, Azamian MS, Robak L, Bostwick BL, Schaaf CP, Potocki L, Scaglia F, Bacino CA, Hanchard NA, Wangler MF, Scott D, Brown C, Hu J, Belmont JW, Burrage LC, Graham BH, Sutton VR, Craigen WJ, Plon SE, Lupski JR, Beaudet AL, Gibbs RA, Muzny DM, Miller MJ, Wang X, Leduc MS, Xiao R, Liu P, Shaw C, Walkiewicz M, Bi W, Xia F, Lee B, Eng CM, Yang Y, Lalani SR. Use of exome sequencing for infants in intensive care units: ascertainment of severe single-gene disorders and effect on medical management. JAMA Pediatr. 2017;171:e173438. Epub 2017 Dec 4
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405-424. Epub 2015 Mar 5
Biglieri EG, Herron MA, Brust N. 17-hydroxylation deficiency in man. J Clin Invest. 1966;45:1946-1954.
Carvalho LC, Brito VN, Martin RM, Zamboni AM, Gomes LG, Inácio M, Mermejo LM, Coeli-Lacchini F, Teixeira VR, Gonçalves FT, Carrilho AJ, Del Toro Camargo KY, Finkielstain GP, Taboada GF, Frade Costa EM, Domenice S, Mendonca BB. Clinical, hormonal, ovarian, and genetic aspects of 46,XX patients with congenital adrenal hyperplasia due to CYP17A1 defects. Fertil Steril. 2016;105:1612-1619. Epub 2016 Feb 23
Zhang M, Sun S, Liu Y, Zhang H, Jiao Y, Wang W, Li X. New, recurrent, and prevalent mutations: clinical and molecular characterization of 26 Chinese patients with 17alpha-hydroxylase/17,20-lyase deficiency. J Steroid Biochem Mol Biol. 2015;150:11-16. Epub 2015 Feb 16
Yanase T, Simpson ER, Waterman MR. 17 alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr Rev. 1991;12:91-108.
Caldwell PH, Deshpande AV, Von Gontard A. Management of nocturnal enuresis. BMJ. 2013;347:f6259.
Wen JG, Wang QW, Chen Y, Wen JJ, Liu K. An epidemiological study of primary nocturnal enuresis in Chinese children and adolescents. Eur Urol. 2006;49:1107-1113. Epub 2005 Dec 27
Kruse A, Mahler B, Rittig S, Djurhuus JC. Increased nocturnal blood pressure in enuretic children with polyuria. J Urol. 2009;182(4 Suppl):1954-1960. Epub 2009 Aug 20
Robinson D, Cardozo L. Estrogens and the lower urinary tract. Neurourol Urodyn. 2011;30:754-757.
Moehrer B, Hextall A, Jackson S. Oestrogens for urinary incontinence in women. Cochrane Database Syst Rev. 2003:CD001405.
Picado-Leonard J, Miller WL. Cloning and sequence of the human gene for P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): similarity with the gene for P450c21. DNA. 1987;6:439-448.
Wang M, Wang H, Zhao H, Li L, Liu M, Liu F, Meng F, Fan C. Prevalence of CYP17A1 gene mutations in 17α-hydroxylase deficiency in the Chinese Han population. Clin Hypertens. 2019;25:23.
Zhao Z, Lu L, Wang O, Wu X, Sun B, Zhang W, Wang X, Mao J, Chen S, Tong A, Nie M. High incidence of hypertension-mediated organ damage in a series of Chinese patients with 17α-hydroxylase deficiency. Endocrine. 2022;76:151-161. Epub 2022 Jan 14
Van Den Akker EL, Koper JW, Boehmer AL, Themmen AP, Verhoef-Post M, Timmerman MA, Otten BJ, Drop SL, De Jong FH. Differential inhibition of 17alpha-hydroxylase and 17,20-lyase activities by three novel missense CYP17 mutations identified in patients with P450c17 deficiency. J Clin Endocrinol Metab. 2002;87:5714-5721.
Nájera N, Garibay N, Pastrana Y, Palma I, Peña YR, Pérez J, Coyote N, Hidalgo A, Kofman-Alfaro S, Queipo G. Loss of cytochrome P450 17A1 protein expression in a 17alpha-hydroxylase/17,20-lyase-deficient 46,XY female caused by two novel mutations in the CYP17A1 gene. Endocr Pathol. 2009;20:249-255.
Wong SL, Shu SG, Tsai CR. Seventeen alpha-hydroxylase deficiency. J Formos Med Assoc. 2006;105:177-181.
Sun M, Yan X, Feng A, Wu X, Ye E, Wu H, Lu X, Yang H. A novel compound heterozygous mutation in the CYP17A1 gene in a patient with 17α-hydroxylase/17,20-lyase deficiency. Discov Med. 2017;24:175-182.
Ten Kate-Booij MJ, Cobbaert C, Koper JW, de Jong FH. Deficiency of 17,20-lyase causing giant ovarian cysts in a girl and a female phenotype in her 46,XY sister: case report. Hum Reprod. 2004;19:456-459.
Yamagata S, Kageyama K, Usui T, Saito K, Takayasu S, Usutani M, Terui K, Daimon M. Identification of a homozygous c.1039C>T (p.R347C) variant in CYP17A1 in a 67-year-old female patient with partial 17α-hydroxylase/17,20-lyase deficiency. Endocr J. 2022;69:115-120. Epub 2021 Sep 3
Afsar J, Kachuei A, Hashemipour M, Larki-Harchegani A, Shabib S. A rare enzymatic defect, true isolated 17,20-lyase deficiency leading to endocrine disorders and infertility: case report. Gynecol Endocrinol. 2020;36:297-302. Epub 2019 Nov 6.
Kardelen AD, Toksoy G, Baş F, Yavaş Abalı Z, Gençay G, Poyrazoğlu Ş, Bundak R, Altunoğlu U, Avcı Ş, Najaflı A, Uyguner O, Karaman B, Başaran S, Darendeliler F. A rare cause of congenital adrenal hyperplasia: clinical and genetic findings and follow-up characteristics of six patients with 17-hydroxylase deficiency including two novel mutations. J Clin Res Pediatr Endocrinol. 2018;10:206-215. Epub 2018 Mar 29
